What is it about?
Companion or Complementary Diagnostics? How do you know which way to go? The best way forward is scenario planning and be prepared for changes in the market be it from the drug label, payers, physicians ... and most importantly, your competitors!
Featured Image
Why is it important?
A good strategy covering all scenarios can means billions in drug sales ... not to mention the optimal patient access to the right drugs.
Read the Original
This page is a summary of: Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch, Clinical and Translational Science, February 2017, Wiley,
DOI: 10.1111/cts.12455.
You can read the full text:
Contributors
The following have contributed to this page
